← Evidence map

ReviewEndocrine pathology2025

The Utility of Cabozantinib in the Therapy of Endocrine Tumours.

Eleni Armeni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41296120